Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer

Clinical trial NCT01151046 · COMPLETED

Trial details

NCT number: NCT01151046
Sponsor: Merrimack Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Her2 Negative Breast Cancer Patients

Start date: 2010-06-01
Primary completion: 2014-06-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.